{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-197192","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.957585+00:00","generated_at":"2026-05-15T01:34:47.439092+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ResMed Q3 revenue $1.43B (+11%); GAAP EPS $2.74, dividend $0.60","bullets":["Revenue $1,431.4M (+11% reported, +8% constant currency).","GAAP diluted EPS $2.74 (+10% YoY); non-GAAP diluted EPS $2.86 (+21% YoY).","GAAP gross margin 62.2% (+290 bps); non-GAAP gross margin 62.8% (+290 bps).","Quarterly dividend $0.60/share declared; record 5/14/2026, payable 6/18/2026.","Operating cash flow $554M; $262M returned via buybacks and dividends in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-197192","json":"https://secwatch.observer/filing/0001193125-26-197192.json","markdown":"https://secwatch.observer/filing/0001193125-26-197192.md","text":"https://secwatch.observer/filing/0001193125-26-197192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/0001193125-26-197192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/d146862d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:34:47.439092+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f57f3cd14e7a478deb3eb9fdf2bcc59430f52bb","claim":"RESMED INC reported the quarter ended March 31, 2026 results: revenue $1,431.4, net income $398.7, EPS $2.74.","evidence_excerpt":"Results and Operating Metrics Unaudited; $ in millions, except for per share amounts Three Months Ended March 31, 2026 March 31, 2025 % Change Constant Currency (A) Revenue $ 1,431.4 $ 1,291.7 11 % 8 % Gross margin 62.2 % 59.3 % 5 Non-GAAP gross margin (B) 62.8 % 59.9 % 5 Selling, general, and administrative expenses 285.7 245.3 16 11 Non-GAAP selling,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/0001193125-26-197192-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Revenue","value":"$1,431.4"},{"label":"Net income","value":"$398.7"},{"label":"EPS","value":"$2.74"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}